A single-institution phase II trial of five fractions of radiotherapy followed by four courses of FOLFOX chemotherapy as preoperative therapy for rectal adenocarcinoma.

被引：4
|
作者：
Myerson, Robert J. [1 ]
Parikh, Parag J. [1 ]
Tan, Benjamin [1 ]
Hunt, Steven [1 ]
Fleshman, James W. [1 ]
Birnbaum, Elisa H. [1 ]
Mutch, Matthew G. [1 ]
Kodner, Ira J. [1 ]
Safar, Bashar [1 ]
Naughton, Michael [1 ]
Picus, Joel [1 ]
Sorscher, Steven [1 ]
Lockhart, Albert Craig [1 ]
Rigden, Caron [1 ]
Suresh, Rama [1 ]
Wang-Gillam, Andrea [1 ]
Hall, Lannis [1 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.553
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
553
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A phase II clinical trial of preoperative chemoradiotherapy (CRT) with oral S-1 plus bevacizumab in patients with middle or lower rectal adenocarcinoma.
    Sadahiro, Sotaro
    Suzuki, Toshiyuki
    Tanaka, Akira
    Okada, Kazutake
    Saito, Gota
    Kamijo, Akemi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [22] Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial
    Burmeister, Bryan H.
    Thomas, Janine M.
    Burmeister, Elizabeth A.
    Walpole, Euan T.
    Harvey, Jennifer A.
    Thomson, Damien B.
    Barbour, Andrew P.
    Gotley, David C.
    Smithers, B. Mark
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (03) : 354 - 360
  • [23] Preoperative, Moderately Hypofractionated Radiotherapy with Image-guided Tomotherapy Concomitant to Chemotherapy in Rectal Adenocarcinoma: Early Results of a Phase II Study
    Passoni, P.
    Ronzoni, M.
    Fiorino, C.
    Slim, N.
    Bencardino, K.
    Di Palo, S.
    Tamburini, A.
    Calandrino, R.
    Staudacher, C.
    Di Muzio, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S274 - S274
  • [24] Phase II trial of first-line chemoradiotherapy with intensity-modulated radiation therapy followed by chemotherapy for synchronous unresectable distant metastases rectal adenocarcinoma
    Zhu, Ji
    Lian, Peng
    Liu, Fangqi
    Xu, Ye
    Xu, Junyan
    Guan, Zuqing
    Liang, Liping
    Wang, Minghe
    Cai, Sanjun
    Zhang, Zhen
    RADIATION ONCOLOGY, 2013, 8
  • [25] Randomized phase II trial of upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy versus preoperative chemoradiotherapy followed by surgery and adjuvant chemotherapy in locally advanced rectal cancer: KCSG-CO14-10
    Beom, S-H.
    Park, S. H.
    Ahn, J. B.
    Kim, H. S.
    Shin, S. J.
    Lee, K. Y.
    Min, B. S.
    Kim, N. K.
    Kim, T.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S726 - S726
  • [26] Phase II trial of first-line chemoradiotherapy with intensity-modulated radiation therapy followed by chemotherapy for synchronous unresectable distant metastases rectal adenocarcinoma
    Ji Zhu
    Peng Lian
    Fangqi Liu
    Ye Xu
    Junyan Xu
    Zuqing Guan
    Liping Liang
    Minghe Wang
    Sanjun Cai
    Zhen Zhang
    Radiation Oncology, 8
  • [27] A phase II trial of preoperative concurrent chemotherapy and dose escalated intensity modulated radiotherapy (IMRT) for locally advanced rectal cancer
    Tey, Jeremy
    Leong, Cheng Nang
    Cheong, Wai Kit
    Sze, Tay Guan
    Yong, Wei Peng
    Tham, Ivan Weng Keong
    Lee, Khai Mun
    JOURNAL OF CANCER, 2017, 8 (16): : 3114 - 3121
  • [28] A phase I/II clinical trial of preoperative docetaxel/oxaliplatin/S-1 (DOS) combination therapy for esophagogastric junction adenocarcinoma.
    Kumagai, Koshi
    Hosoda, Kei
    Niihara, Masahiro
    Katada, Chikatoshi
    Ishido, Kenji
    Watanabe, Akinori
    Wada, Takuya
    Sakuraya, Mikiko
    Washio, Marie
    Higuchi, Tadashi
    Chuman, Motohiro
    Harada, Hiroki
    Yamashita, Keishi
    Kusano, Chika
    Hiki, Naoki
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 429 - 429
  • [29] Preoperative hyperfractionated accelerated radiotherapy (HART) in locally advanced rectal cancer (LARC) immediately followed by surgery. A prospective phase II trial
    Coucke, Philippe A.
    Notter, Markus
    Stamm, Bernhard
    Matter, Maurice
    Fasolini, Fabrizio
    Schlumpf, Rolph
    Matzinger, Oscar
    Bouzourene, Hanifa
    RADIOTHERAPY AND ONCOLOGY, 2006, 79 (01) : 52 - 58
  • [30] Phase II single-arm, single-institution trial of neoadjuvant gemcitabine and oxaliplatin treatment (NT) in patients (pts) with resectable pancreas adenocarcinoma (PC)
    O'Reilly, E. M.
    Jarnagin, W. R.
    Brennan, M. F.
    Winston, C.
    Tang, L. H.
    Capanu, M.
    Schattner, M.
    Chen, L. Y.
    DeMatteo, R. P.
    DiMaio, C. J.
    D'Angelica, M. I.
    Kurtz, R. C.
    Klimstra, D. S.
    Lowery, M. A.
    Coit, D. G.
    Reidy, D. L.
    Allen, P. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345